Catalysts Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 06-10-2024
- Paid Up Capital ₹ 2.02 M
as on 06-10-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.60 M
as on 06-10-2024
- Satisfied Charges ₹ 4.15 Cr
as on 06-10-2024
- Revenue 57.25%
(FY 2023)
- Profit 36.23%
(FY 2023)
- Ebitda 35.01%
(FY 2023)
- Net Worth 46.69%
(FY 2023)
- Total Assets 42.74%
(FY 2023)
About Catalysts Bio-Technologies
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 2.02 M.
The company currently has active open charges totaling ₹8.60 M. The company has closed loans amounting to ₹4.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Poonam Madan, Munish Madan, and Om Shukla serve as directors at the Company.
- CIN/LLPIN
U24234DL2007PTC159686
- Company No.
159686
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Catalysts Bio-Technologies Private Limited offer?
Catalysts Bio-Technologies Private Limited offers a wide range of products and services, including Organic Food Grains & Vegetables, Organic Sugar, Flavours & Aromatics, Starch Powder.
Who are the key members and board of directors at Catalysts Bio-Technologies?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Munish Madan | Managing Director | 23-Feb-2007 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Poonam Madan | Director | 18-Apr-2020 | Current |
Om Shukla | Director | 18-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Catalysts Bio-Technologies.
Catalysts Bio-Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.25% increase. The company also saw a substantial improvement in profitability, with a 36.23% increase in profit. The company's net worth Soared by an impressive increase of 46.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Catalysts Bio-Technologies?
In 2023, Catalysts Bio-Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Naturegen Biotechnologies LlpActive 2 years 6 months
Poonam Madan and Munish Madan are mutual person
- Catalysts Biochemicals Private LimitedActive 9 months 2 days
Poonam Madan and Munish Madan are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 09 Nov 2020 | ₹5.00 M | Open |
Axis Bank Limited Creation Date: 29 Sep 2020 | ₹1.80 M | Open |
Hdfc Bank Limited Creation Date: 21 Feb 2017 | ₹1.80 M | Open |
How Many Employees Work at Catalysts Bio-Technologies?
Catalysts Bio-Technologies has a workforce of 86 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catalysts Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catalysts Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.